2,654
edits
No edit summary |
No edit summary |
||
Line 65: | Line 65: | ||
:*Facilitate contact with an investigator or obtain their written authorization to share their interest in study participation with the investigators and to be contacted by them. The honest broker would not directly contact the patient. | :*Facilitate contact with an investigator or obtain their written authorization to share their interest in study participation with the investigators and to be contacted by them. The honest broker would not directly contact the patient. | ||
:*After secondary review by the Associate Vice Chancellor for Clinical Research, an honest broker may provide the research investigator with a list of potentially eligible patients who have agreed to be contacted for research studies they are eligible for based on their election on the Conditions of Treatment form or consistent with the Human Research Protection Program Policy #3.4 “Use of Protected Health Information in Research and Registries” for further information. | :*After secondary review by the Associate Vice Chancellor for Clinical Research, an honest broker may provide the research investigator with a list of potentially eligible patients who have agreed to be contacted for research studies they are eligible for based on their election on the Conditions of Treatment form or consistent with the Human Research Protection Program Policy #3.4 “Use of Protected Health Information in Research and Registries” for further information. | ||
* | *Honest broker Data Requests: Individuals requesting PHI or de-identified data shall complete the [https://unmcredcap.unmc.edu/redcap/surveys/?s=9TsTE2UGsM UNMC/Nebraska Medicine EHR Service Request Form] (research), the [http://newintranet.nebraskamed.com/AnalyticsRequest/Login.aspx?ReturnUrl=%2fanalyticsrequest%2f Analytics Request Form] (performance improvement) or another similar form. | ||
===Honest Broker Certification Criteria=== | ===Honest Broker Certification Criteria=== | ||
*Appointment: honest brokers shall not be a part of the research team for which they are performing honest broker services, unless approved by the ACE Privacy Officer, the Associate Vice Chancellor for Clinical Research and the Chief, Quality/Outcomes Officer. | *Appointment: honest brokers shall not be a part of the research team for which they are performing honest broker services, unless approved by the ACE Privacy Officer, the Associate Vice Chancellor for Clinical Research and the Chief, Quality/Outcomes Officer. |